Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
VB

Vanta Bioscience Ltd

540729·Healthcare

Vanta Bioscience Ltd is in the business of Preclinical Activities.Business Overview: The company is a preclinical contract research organization, offering preclinical safety assessment services for clientele from the Pharmaceutical, Medical Devices, Nutraceuticals, Feed additives, Biotech, Agrochemicals, Cosmetics, and Chemical industries. In addition, the company also provides risk assessment services for...

23Announcements
05-09-2026Last filed
1Last 90 days
vantabio.com

What Vanta files

  • Others6
  • Updates5
  • Board Meeting5
  • Important3
  • Results2
  • Insider Trade1
Showing Updates announcements (5)Clear filter
29-07-2025 · 06:33 pm

Vanta Bioscience Limited has announced a board meeting on August 01, 2025, at 6:00 PM to consider and approve the financial results for the period ended March 31, 2025. This meeting was previously scheduled for July 29, 2025, but was postponed due to unforeseen circumstances. The trading window for designated...

Read the full announcement→
PDF
26-07-2025 · 06:40 pm

Vanta Bioscience has announced a board meeting on July 29, 2025, to approve the financial results for the period ended March 31, 2025. This meeting was rescheduled from an earlier date due to unforeseen circumstances. For investors, this means a slight delay in the financial update. The trading window for...

Read the full announcement→
PDF
19-07-2025 · 09:49 pm

Vanta Bioscience Limited has announced a board meeting on July 24, 2025, to consider and approve the financial results for the period ended March 31, 2025. This meeting was originally scheduled for July 19, 2025, but was postponed due to unforeseen and unavoidable circumstances. The delay means shareholders will receive...

Read the full announcement→
PDF
16-06-2025 · 10:57 pm

Vanta Bioscience has had its application to reclassify promoters Dr. Vyasmurti Madhavrao Shingatgeri and Mr. Pradeep Chowdary Veeramachineni as public shareholders rejected by BSE. This maintains the current promoter and public shareholding status, which could affect the company’s governance and control dynamics. The decision impacts shareholders by preserving the existing...

Read the full announcement→
PDF
02-05-2025 · 06:47 pm

Vanta Bioscience has announced a board meeting. The company has successfully received the National Good Laboratory Practice (GLP) re-certification for its Gummidipundi facility in Tamil Nadu, valid for three years. This certification confirms compliance with OECD GLP standards and reflects the company’s commitment to international quality. It is expected to...

Read the full announcement→
PDF